Am J Perinatol 2024; 41(11): 1504-1511
DOI: 10.1055/a-2118-5351
Original Article

Reintubation Rate between Nasal High-Frequency Oscillatory Ventilation versus Synchronized Nasal Intermittent Positive Pressure Ventilation in Neonates: A Parallel Randomized Controlled Trial

Manapat Phatigomet
1   Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
,
1   Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
,
1   Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
,
Supaporn Dissaneevate
1   Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
,
Waricha Janjindamai
1   Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
› Author Affiliations

Funding This study was supported by the Faculty of Medicine, Prince of Songkla University, Thailand (grant number: REC. 62-382-1-1).
Preview

Abstract

Objective Nasal high-frequency oscillatory ventilation (nHFOV) and synchronized nasal intermittent positive pressure ventilation (sNIPPV) were the new modes of noninvasive ventilation. This study's aim was to clarify as to which of the nHFOV and sNIPPV modes was superior in preventing postextubation failure or reintubation in neonates.

Study Design An open-label parallel randomized study was performed. Extubated preterm and term neonates were randomly allocated into nHFOV or sNIPPV modes; the reintubation rate was evaluated within 7 days after extubation between the two modes. Subgroup analyses were performed for preterm (gestational age <37 weeks) and very preterm (gestational age <32 weeks) neonates. The sample calculation was 1,050 neonates; however, this trial was stopped early as enrollment was too slow.

Results From July 2020 to June 2022, 202 neonates were assessed for eligibility and 69 neonates were excluded. Finally, 133 neonates were randomly allocated to the study interventions (nHFOV = 67, sNIPPV = 66). The median gestational age and birth weight were 33 (30–37) weeks and 1,910 (1,355–2,836) g, respectively. The reintubation rate within 7 days did not significantly differ between the groups (nHFOV [5/67, 7%] vs. sNIPPV [4/66, 6%]); risk difference [95% confidence interval] = 0.01 [−0.08 to 0.11]; p = 0.99), including preterm (nHFOV [4/55, 7%] vs. sNIPPV [3/44, 7%]) and very preterm (nHFOV [3/25, 12%] vs. sNIPPV [3/25, 12%]) neonates.

Conclusion After neonatal extubation, there was no significant difference of reintubation rates within 7 days between nHFOV and sNIPPV. This trial has been registered in the ClinicalTrials.gov database ( https://clinicaltrials.gov/ct2/show/NCT04323397 ). First posted registration on March 26, 2020.

Key Points

  • There was no significant difference of reintubation rates between nHFOV and sNIPPV.

  • During nHFOV support, one neonate developed pneumomediastinum.

  • During sNIPPV support, one neonate developed pulmonary hemorrhage.

Note

This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving research study participants were approved by the institutional Ethics Committee. Written informed consent was obtained from all participants. This trial has been registered in the ClinicalTrials.gov database ( https://clinicaltrials.gov/ct2/show/NCT04323397 ). First posted registration on March 26, 2020.


Authors' Contributions

M.P. and A.T. designed the data collection instruments, collected data, performed the initial analyses, and drafted the initial manuscript, reviewed, and revised the manuscript. All authors conceptualized and designed the study, coordinated, and supervised data collection; critically reviewed the manuscript for important intellectual content, and approved the final manuscript, as submitted, and agree to be accountable for all aspects of the work.


Supplementary Material



Publication History

Received: 11 April 2023

Accepted: 26 June 2023

Accepted Manuscript online:
27 June 2023

Article published online:
29 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA